To assess if hypertension during the last part of pregnancy could be prevented by magnesium supplementation.
Pregnant primagravida women from a local antenatal care unit were given an oral supply of 300 mg magnesium as citrate or placebo from pregnancy week 25 in a randomised double-blind setup. Blood pressure was recorded during pregnancy as well as pregnancy outcome.
In the magnesium-supplemented group, the average diastolic blood pressure at week 37 was significantly lower than in the placebo group (72/1.4 mean/SEM vs 77/1.4, p = 0.031). The number of women with an increase in diastolic blood pressure of ≥15 mmHg was significantly lower in the magnesium group compared with the women who received placebo (p = 0.011). There was an inverse relation between the urinary excretion of magnesium during pregnancy and the diastolic blood pressure (p = 0.005).
Magnesium supplementation prevented an increase in diastolic blood pressure during the last weeks of pregnancy. The relation between diastolic blood pressure and urinary excretion of magnesium suggests that magnesium is involved in the regulation of blood pressure and that the increase in diastolic blood pressure in pregnancy could be due to a lack of magnesium.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
(2000) Report of the national high blood pressure program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 183:S1–S22
Backes CH, Markham K, Moorehead P, Cordero L, Nankervis CA, Giannone PJ (2011) Maternal preeclampsia and neonatal outcomes. J Pregnancy 2011:214365
Duley L (2009) The global impact of pre-eclampsia and eclampsia. Semin Perinatol 33:130–137
Richie LD, King JC (2001) Dietary calcium and pregnancy-induced hypertension: is there a relation? Am J Clin Nutr 71(suppl):1371S–1374S
Suarez VR, Trelles JG, Miyahira JM (1996) Urinary calcium in asymptomatic primigravidas who later developed preeclampsia. Obstet Gynecol 87:79–82
Taufield PA, Ales KL, Resnick LM, Druzin ML, Gertner JM, Laragh JH (1987) Hypocalcuria in preeclampsia. New Engl J Med 316:715–718
Trumbo PR, Ellwood KC (2007) Supplemental calcium and risk reduction of hypertension, pregnancy-induced hypertension, and preeclampsia: an evidence-based review by the US Food and Drug Administration. Nutr Rev 65:78–86
López-Jaramillo P, Garcia RG, López M (2005) Preventing pregnancy-induced hypertension: are there regional differences for this global problem? J Hypertens 23:1121–1129
Oken E, Ning Y, Rifas- Shiman SL, Rich-Edwards JW, Olsen SF, Gillman MW (2007) Diet during pregnancy and risk of preeclampsia or gestational hypertension. Ann Epidemiol 17:663–668
Conradt A (1985) Pathophysiology and clinical aspects of pre-eclampsia. Z Geburtshilfe Perinatol 189:149–161
Jain S, Sharma P, Kulshreshtha S, Mohan G, Singh S (2010) The role of calcium, magnesium, and zinc in pre-eclampsia. Biol Trace Elem Res 133:162–170
Indumati V, Kodliwadmath MV, Sheela MK (2011) The role of serum electrolytes in pregnancy induced hypertension. J Clin Diagnostic Res 5:66–69
Kisters K, Barenbrock M, Louwen F, Hausberg M, Rahn KH, Kosch M (2000) Membrane, intracellular, and plasma magnesium and calcium concentrations in preeclampsia. Am J Hypertens 13:765–769
Adam B, Malatyalioğlu E, Alvur M, Talu C (2001) Magnesium, zinc and iron levels in pre-eclampsia. J Matern Fetal Med 10:246–250
Kisters K, Körner J, Louwen F, Witteler R, Jackisch C, Zidek W et al (1968) Plasma and membrane Ca2+ and Mg2+ concentrations in normal pregnancy and in preeclampsia. Gynecol Obstet Invest 46:158–163
Resnick LM, Barbagallo M, Bardicef M, Bardicef O, Sorokin Y, Evelhoch J et al (2004) Cellular-free magnesium depletion in brain and muscle of normal and preeclamptic pregnancy: a nuclear magnetic resonance spectroscopic study. Hypertension 44:322–326
Idogun ES, Imarengiaye CO, Momoh SM (2007) Extracellular calcium and magnesium in preeclampsia and eclampsia. Afr J Reprod Health 11:89–94
Duley L, Matar HE, Almerie MQ, Hal lDR (2010) Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia. Cochrane Database Syst Rev 8:CD0077388:1
McDonald SD, Lutsiv O, Dzaja N, Duley L (2012) A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia/eclampsia in real-world use. Int J Gynecol Obstetr 118:90–96
Sugimoto J, Romani AM, Valentin-Torres AM, Luciano AA, Ramirez-Kitchen CM, Funderburg N, Mesiano S et al (2012) Magnesium decreases inflammatory cytokine production: a novel innate immunomodulatory mechanism. J Immunol 188:6338–6346
Amash A, Weintraub AY, Sheiner E, Zeadna A, Huleihel M, Holcberg G (2010) Possible therapeutic effect of magnesium sulphate in pre-eclampsia by the down-regulation of placental tumor necrosis factor-alpha secretion. Eur Cytokine Netw 1:58–64
Amash A, Holcberg G, Sheiner E, Huleihel M (2010) Magnesium sulfate normalizes placental interlukin-6 secretion in preeclampsia. J Interferon Cytokine Res 30:683–690
Rudnicki M, Frolich A, Fischer-Rasmussen W, McNair P (1991) The effect of magnesium on maternal blood pressure in pregnancy-induced hypertension—a randomised double-blind placebo-controlled trial. Acta Obstet Gynecol 70:445–450
Sibai BM, Villar MA, Brazy E (1989) Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. Am J Obstetr Gynecol 161:115–119
Kovács L, Molnár BG, Huhn E, Bódis L (1998) Magnesium substitution in pregnancy. A prospective, randomized double-blind study. Geburtshilfe Frauenheilkd 48:595–600
Makrides M, Crowther CA (2001) Magnesium supplementation in pregnancy. Cochrane Database Syst Rev (4):CD000937. doi:10.1002/14651858.CD000937
Nielsen TF, Rylander R (2011) Urinary calcium and magnesium excretion relates to increased blood pressure during pregnancy. Arch Gynecol Obstetr 283:443–447
Rylander R, Tallheden T, Vormann J (2009) Acid–base conditions regulate calcium and magnesium homeostasis. Magnesium Res 22:1–4
Rylander R, Remer T, Berkemeyer S, Vormann J (2006) Acid–base status affects renal magnesium losses in healthy, elderly persons. J Nutrition 36:2374–2377
Remer T (2001) Influence of nutrition on acid–base balance—metabolic aspects. Eur J Nutr 40:214–220
Chiuve SE, Korngold EC, Januzzi JL, Gantzer ML, Albert CM (2010) Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr 93:253–260. doi:10.3945/ajcn.110.002253
Jee SH, Miller ER, Guallar E, Singh VK, Appel LJ, Klag MJ (2002) The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens 15:691–696
The study was supported by grants from the Research and Development Foundation at Södra Älvsborg, Alice Swenzon’s Foundation, Swedbank Sjuhärad Research Foundation, Sweden, and Protina GmbH, Ismaning, Germany.
Ethical committee approval was obtained (ECG T 515-10, 098-09, Ethical Committee, Gothenburg University 8 April 2009) as well as permission to register according to Swedish law on personal information. Informed consent was obtained from all participants. Registration at ISRCTN98365455.
Conflict of interest
The authors report no conflict of interest. Dr Vormann is a scientific consultant to Protina GmbH.
Trial registration number: ISRCTN 98365455. www.controlled-trials.com.
Rights and permissions
About this article
Cite this article
Bullarbo, M., Ödman, N., Nestler, A. et al. Magnesium supplementation to prevent high blood pressure in pregnancy: a randomised placebo control trial. Arch Gynecol Obstet 288, 1269–1274 (2013). https://doi.org/10.1007/s00404-013-2900-2
- Pregnancy-induced hypertension